Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion, Zambon SpA, Mallinckrodt, Incyte Corporation, GlaxoSmithKline, Mereo Biopharma, Genentech
February 29, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion,...
Vasomotor Symptoms Market is Likely to Increase at a Steady Growth Rate by 2034, Estimated DelveInsight | Key Companies - Estetra, Bayer, Hansoh BioMedical R&D Company, Mitsubishi Tanabe Pharma, Astellas Pharma Inc
February 28, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Vasomotor Symptoms Market is Likely to Increase at a Steady Growth Rate by 2034, Estimated DelveInsight | Key Companies - Estetra, Bayer, Hansoh...
Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight
February 27, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight An increase in the prevalence,...
Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene Therapeutics, Pfizer, Genentech, Incyte Corporation, Bristol-Myers Squibb
February 26, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene...
Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight
February 22, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight The dynamics of the short...
Ascites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsight
February 21, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ascites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsight The rise in the patient population of ascites, the...
PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight
February 20, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight The PD-1 and PD-L1 inhibitor...
Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
February 19, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics, Skingenix, Inc., Stratatech, MediWound Ltd
February 15, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics,...
Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight
February 14, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight The gene and cell...